Home › Research › Tau biomarkers
Oxysterols as markers of neurological disease--a review
Leoni V.. Scandinavian journal of clinical and laboratory investigation, 2009-01-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Cholesterol plays a crucial structural role in the brain and local synthesis covers almost all the requirements of the brain. To maintain homeostasis, the excess of cholesterol is converted into the more hydrophilic oxysterol 24S-hydroxycholesterol by the neuron-specific enzyme CYP46A1. About 99% of the total excretion of this oxysterol by the brain occurs across the blood-brain barrier directly into the bloodstream.
What this study adds
Evidence grade: Low
This is a narrative review. This review describes how the brain converts excess cholesterol into 24S-hydroxycholesterol and how this oxysterol enters the bloodstream. It is a general review and does not test any treatment, cure, or prevention for Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Leoni, V. (2009). Oxysterols as markers of neurological disease--a review. Scandinavian journal of clinical and laboratory investigation. https://doi.org/10.1080/00365510802651858
Vancouver
Leoni V. Oxysterols as markers of neurological disease--a review. Scandinavian journal of clinical and laboratory investigation. 2009. doi:10.1080/00365510802651858. PMID: 19199127.
BibTeX
@article{leoni2009-19199127,
author = {Leoni, V.},
title = {{Oxysterols as markers of neurological disease--a review}},
journal = {Scandinavian journal of clinical and laboratory investigation},
year = {2009},
doi = {10.1080/00365510802651858},
pmid = {19199127},
url = {https://doi.org/10.1080/00365510802651858}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- To maintain homeostasis, the excess of cholesterol is converted into the more hydrophilic oxysterol 24S-hydroxycholesterol by the neuron-specific enzyme CYP46A1.
- About 99% of the total excretion of this oxysterol by the brain occurs across the blood-brain barrier directly into the bloodstream.
- Almost all the 24S-hydroxycholesterol present in human circulation has a cerebral origin and its concentrations depend on the number of metabolically active neurons located in the grey matter of the brain.
- Neurodegeneration, with loss of neurons, and the subsequent brain atrophy are associated with significantly reduced concentrations of oxysterols. 24S-Hydroxycholesterol can thus be used as a surrogate marker of brain atrophy in neurodegenerative diseases such as Alzheimer and multiple sclerosis.
Why it matters
This review describes how the brain converts excess cholesterol into 24S-hydroxycholesterol and how this oxysterol enters the bloodstream. It is a general review and does not test any treatment, cure, or prevention for Alzheimer's disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Scandinavian journal of clinical and laboratory investigation) |
| Journal's citation record | 2 / 4 | Scandinavian Journal of Clinical and Laboratory Investigation: journal h-index 154 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2009 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 73 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.8 citations a year over 19 year(s) since 2009 |
| Impact for its field and year | 3 / 6 | Cited 5.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Valerio Leoni: h-index 46 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Fondazione IRCCS Istituto Neurologico Carlo Besta: institution h-index 417 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 19199127) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Tau biomarkers from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.